Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10273237B2
公开(公告)日:2019-04-30
Compounds having the following formula (I), or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
具有下式(I)的化合物或其立体异构体或药学上可接受的盐,其中 R1、R2、R3、R4 和 R5 如本文所定义,通过作用于 Tyk-2,导致信号转导抑制,可用于调节 IL-12、IL-23 和/或 IFNα。